erratum
TRANSCRIPT
Wang et al.Wave Reflection With Vasodilation and Vasoconstriction
253
16. Fitchett DH, Simkus GJ, Beaudry JP, Marpole DG. Reflected pressurewaves in the ascending aorta: effect of glyceryl trinitrate. Cardiovasc Res1988;22:494-500.
17. Yaginuma T, Avolio A, O’Rourke M, et al. Effect of glyceryl trinitrate onperipheral arteries alters left ventricular hydraulic load in man. CardiovascRes 1986;20:153-60.
18. O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treat-ment of arterial hypertension. Hypertension 1990;15:339-47.
19. Anderson WP, Korner PI. The importance of renal vascular tone in de-termining the severity of renal artery stenosis in dogs. J Physiol 1980;305:31-41.
20. Brin KP, Yin FC. Effect of nitroprusside on wave reflections in patientswith heart failure. Ann Biomed Eng 1984;12:135-50.
21. Quick CM, Berger DS, Stewart RH, Laine GA, Hartley CJ, NoordergraafA. Resolving the hemodynamic inverse problem. IEEE Trans Biomed Eng
Erratu
Auleen Millar, MB, BCh, BAO, MRCP(UK), Paul K.
22. Wang JJ, Parker KH. Wave propagation in a model of the arterial circu-lation. J Biomech 2004;37:457-70.
23. Wang JJ, Parker KH, Tyberg JV. Left ventricular wave speed. J ApplPhysiol 2001;91:2531-6.
24. Rouleau JL. New and emerging drugs and device therapies for chronicheart failure in patients with systolic ventricular dysfunction. Can J Car-diol 2011;27:296-301.
25. Wood P, Piran S, Liu PP. Diastolic heart failure: progress, treatmentchallenges, and prevention. Can J Cardiol 2011;27:302-10.
Supplementary MaterialTo access the supplementary material accompanying this
article, visit the online version of the Canadian Journal of Car-diology at www.onlinecjc.ca and at http://dx.doi.org/10.1016/
2006;53:361-8. j.cjca.2012.03.001.
m
In the article, “Lifetime Risk of Cardiovascular Disease: TheNext Generation in Risk Prediction” by Bleakley et al. (CanJ of Cardiol 2013;29:147-50.), the authors regret that authorPaul K. Hamilton is missing from the author list. The correctlist of authors and affiliations is as follows:Caroline Bleakley, MB, BCh, BAO, MRCP(UK),
Hamilton, MB, BCh, BAO, MRCP(UK), Mark Harbin-son, MD, FRCP(UK), and Gary Eugene McVeigh, MD,FRCP(UK)
Department of Cardiovascular Therapeutics and Pharmacology,Queen’s University Belfast, Whitla Medical Building, Northern
Ireland, United Kingdom